WASHINGTON — Federal health officials say they still have safety concerns about an experimental diet pill from drugmaker Vivus, as the company prepares to make a second attempt to convince experts of the drug’s safety next week. Vivus, based in Mountain View, Calif., is one of three small drugmakers racing to bring the first new ...Read More

JACKSONVILLE, Fla. – This week the FDA is set to re-consider a diet pill drug it has already rejected. If it’s passed, it would be the first new prescription diet pill in 13 years. The drug is called Qnexa, but there are serious health concerns, including heart risk and birth defects. Pharmacist Gary Roberts said, ...Read More